NEWS ROOM
- 2024.12.26Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders Press Release
- 2024.12.23Presentation at the 43rd Annual J.P.Morgan Healthcare Conference Topics
- 2024.11.19ARCALIS Signs a Memorandum of Understanding with Fukushima Medical University and Fukushima Translational Research Foundation for Comprehensive Collaboration on Research, Development and Manufacturing of mRNA Pharmaceuticals and Vaccines Press Release
- 2024.11.14Meiji Seika Pharma Announces Investment in ARCALIS, Inc. Press Release
- 2024.10.02Meiji Seika Pharma Submits Application to Amend Approval for KOSTAIVE®, a Self-Amplifying mRNA Vaccine against COVID-19, to Include Domestic Manufacturing Site in Japan Topics